The Russian market is strategically one of the most important for Gedeon Richter, we strive to contribute to the growth of life quality and life expectancy of Russians. Over the decades of work in this region, the company has been able to prove its commitment to the interests of patients as well as the pharmaceutical and healthcare industries in general.
Today it is safe to say that most of our products have already proven themselves in the clinical practice of Russian specialists and are widely used. And we, in turn, make every effort to ensure that our drugs are available for our patients.
Along with the achievement of high efficacy, safety and availability of our medicines, Gedeon Richter strives to maintain a consistently high level of quality of our products. To do so we introduced a unified multi-stage control system at each of our factories, which was approved by Russian and foreign regulators.
We are pleased that for the past four years the GMP Conference with International Participation has brought together industry experts and stimulated a productive dialogue to discuss topical issues for the benefit of the industry.
I wish you a successful conference and fruitful work! Thank you!
Deputy Director, Head of Registration Department
Gedeon Richter, Moscow office